These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 282086)

  • 41. Anti-hypertensive drugs in pregnancy and fetal growth: evidence for "pharmacological programming" in the first trimester?
    Bayliss H; Churchill D; Beevers M; Beevers DG
    Hypertens Pregnancy; 2002; 21(2):161-74. PubMed ID: 12175444
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effect of magnesium on maternal blood pressure in pregnancy-induced hypertension. A randomized double-blind placebo-controlled trial.
    Rudnicki M; Frölich A; Rasmussen WF; McNair P
    Acta Obstet Gynecol Scand; 1991; 70(6):445-50. PubMed ID: 1763608
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of atenolol on birth weight.
    Lip GY; Beevers M; Churchill D; Shaffer LM; Beevers DG
    Am J Cardiol; 1997 May; 79(10):1436-8. PubMed ID: 9165181
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Sublingual nifedipine in human pregnancy.
    Gallery ED; Györy AZ
    Aust N Z J Med; 1997 Oct; 27(5):538-42. PubMed ID: 9404584
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Trial of combination of guanethidine and oxprenolol in hypertension.
    Pearson RM; Bending MR; Bulpitt CJ; George CF; Hole DR; Williams FM; Breckenridge AM
    Br Med J; 1976 Apr; 1(6015):933-6. PubMed ID: 773486
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Atenolol in the treatment of pregnancy-induced hypertension.
    Thorley KJ; McAinsh J; Cruickshank JM
    Br J Clin Pharmacol; 1981 Nov; 12(5):725-30. PubMed ID: 7332738
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Outcome of pregnancies complicated by severe hypertension and delivered before 34 weeks; stepwise logistic regression analysis of prognostic factors.
    Derham RJ; Hawkins DF; De Vries LS; Aber VR; Elder MG
    Br J Obstet Gynaecol; 1989 Oct; 96(10):1173-81. PubMed ID: 2590653
    [TBL] [Abstract][Full Text] [Related]  

  • 48. High risk hypertensive pregnancies: maternal and foetal outcome.
    Horvath JS; Phippard A; Smart DH; Korda A; Duggin GG; Hall BM; Tiller DJ
    Clin Exp Hypertens B; 1983; 2(1):21-8. PubMed ID: 6872279
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A comparative evaluation of metoprolol and methyldopa in the management of pregnancy induced hypertension.
    Oumachigui A; Verghese M; Balachander J
    Indian Heart J; 1992; 44(1):39-41. PubMed ID: 1398694
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Interaction between oxprenolol and indomethacin on blood pressure in essential hypertensive patients.
    Salvetti A; Arzilli F; Pedrinelli R; Beggi P; Motolese M
    Eur J Clin Pharmacol; 1982; 22(3):197-201. PubMed ID: 7049707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The renin-angiotensin-aldosterone system and blood pressure during oxprenolol treatment in hypertensive patients pretreated with diuretics.
    Salvetti A; Pedrinelli R; Simonini N
    Int J Clin Pharmacol Ther Toxicol; 1982 Nov; 20(11):538-42. PubMed ID: 6757151
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Oxprenolol in hypertension: a report on 2,770 patients in general practice originally treated with methyldopa.
    Forrest WA
    Scott Med J; 1976 Jan; 21(1):28-30. PubMed ID: 1257736
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparison of slow release oxprenolol with conventional oxprenolol in the treatment of hypertension.
    Resnekov EB; Havard CW
    Eur J Clin Pharmacol; 1978 Nov; 14(2):77-81. PubMed ID: 363434
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infant growth and development after treatment of maternal hypertension.
    Myerscough PR
    Lancet; 1980 Apr; 1(8173):883. PubMed ID: 6103245
    [No Abstract]   [Full Text] [Related]  

  • 55. Placebo-controlled trial of atenolol in treatment of pregnancy-associated hypertension.
    Rubin PC; Butters L; Clark DM; Reynolds B; Sumner DJ; Steedman D; Low RA; Reid JL
    Lancet; 1983 Feb; 1(8322):431-4. PubMed ID: 6131164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The evaluation of labetalol in the treatment of hypertension complicating pregnancy.
    Michael CA
    Br J Clin Pharmacol; 1982 Jun; 13(1 Suppl):127S-131S. PubMed ID: 7093096
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis.
    von Dadelszen P; Ornstein MP; Bull SB; Logan AG; Koren G; Magee LA
    Lancet; 2000 Jan; 355(9198):87-92. PubMed ID: 10675164
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effects of prophylactic management and therapeutics on hypertensive disease in pregnancy: preliminary studies.
    Welt SI; Dorminy JH; Jelovsek FR; Crenshaw MC; Gall SA
    Obstet Gynecol; 1981 May; 57(5):557-65. PubMed ID: 7219904
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Treatment of arterial hypertension in the pregnant woman with labetalol. A propos of 24 cases].
    Dubois D; Petitcolas J; Temperville B; Klepper A; Leboullenger P
    J Gynecol Obstet Biol Reprod (Paris); 1984; 13(6):691-700. PubMed ID: 6520355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Beta blockade in essential hypertension: an analysis of response to oxprenolol.
    Barritt DW; Marshall AJ
    Br Heart J; 1977 Aug; 39(8):825-8. PubMed ID: 901673
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.